Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Chronic Disease Management Market, by Type
1.4.2 North America Chronic Disease Management Market, by End User
1.4.3 North America Chronic Disease Management Market, by Disease Type
1.4.4 North America Chronic Disease Management Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep – 2022, May) Leading Players
Chapter 4. North America Chronic Disease Management Market by Type
4.1 North America Solutions Market by Country
4.2 North America Services Market by Country
Chapter 5. North America Chronic Disease Management Market by End User
5.1 North America Healthcare Providers Market by Country
5.2 North America Healthcare Payers Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Chronic Disease Management Market by Disease Type
6.1 North America Diabetes Market by Country
6.2 North America Cardiovascular diseases Market by Country
6.3 North America Asthma Market by Country
6.4 North America Chronic obstructive pulmonary disorders Market by Country
6.5 North America Cancer Market by Country
6.6 North America Others Market by Country
Chapter 7. North America Chronic Disease Management Market by Country
7.1 US Chronic Disease Management Market
7.1.1 US Chronic Disease Management Market by Type
7.1.2 US Chronic Disease Management Market by End User
7.1.3 US Chronic Disease Management Market by Disease Type
7.2 Canada Chronic Disease Management Market
7.2.1 Canada Chronic Disease Management Market by Type
7.2.2 Canada Chronic Disease Management Market by End User
7.2.3 Canada Chronic Disease Management Market by Disease Type
7.3 Mexico Chronic Disease Management Market
7.3.1 Mexico Chronic Disease Management Market by Type
7.3.2 Mexico Chronic Disease Management Market by End User
7.3.3 Mexico Chronic Disease Management Market by Disease Type
7.4 Rest of North America Chronic Disease Management Market
7.4.1 Rest of North America Chronic Disease Management Market by Type
7.4.2 Rest of North America Chronic Disease Management Market by End User
7.4.3 Rest of North America Chronic Disease Management Market by Disease Type
Chapter 8. Company Profiles
8.1 Infosys Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 ExlService Holdings, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.3 Health Catalyst, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 AllScripts Healthcare Solutions, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expenses
8.5 Koninklijke Philips N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.5.4 Approvals and Trials:
8.6 Cognizant Technology Solutions Corporation
8.6.1 Company overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.5 SWOT Analysis
8.7 Casenet, LLC (Zyter, Inc.)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Cedar Gate Technologies
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 Clinical Excellence, Inc.
8.9.1 Company Overview
8.10. Altruista Health, Inc. (HealthEdge Software, Inc.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:
Unique Offerings 
